News & Articles

Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions

Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%

First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination

Workflow is quick, simple and scalable for high-throughput antibody detection with high PPA sensitivity and NPA specificity

Supports cross-functional teams of chemists and biologists developing non-natural, chemically modified therapeutics for drug discovery

A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK as early as autumn, thanks to a £1.9million award from the UK government

The overall goal is to continue to detect and discover critical components in the overall cellular response to COVID-19

Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season

Access Anti-SARS-CoV-2 is an easy-to-use 10-minute test on a portable device that provides highly accurate results on total Ig antibodies

Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S.

It is the first and only approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel recycling antibody technology

IgM assay has 95.51% positive predictive value even when disease incidence is only 3%

Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB, the test could help fill a critical gap that is jeopardizing global TB targets

Leveraging GenMark’s eSensor XT-8 platform hopes to expand COVID-19 diagnostic testing capacity

Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses

Watch this on-demand webinar to learn all about the new alternative to live virus neutralization and immunoglobulin detection

Dr. Carol Treasure discusses her hopes to accelerate the world’s transition to completely animal-free testing, to produce safe cosmetics and improve skin sensitization testing

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails

Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours

BLENREP is the fifth major medicine approval for GSK in 2020